Table 2.
Cytokine | Baseline | Follow-up | ||
---|---|---|---|---|
|
|
|||
Fresh | Cryopreserved | Fresh | Cryopreserved | |
Th1/Th2 | 12.49 (13.00) | 17.28 (13.54) | 7.46 (6.34) | 5.57 (18.44) |
Th1 | 14.83 (10.29) | 21.45 (7.56) | 18.20 (8.90) | 13.34 (7.10) |
Th2 | 1.67 (0.99) | 1.93 (1.32) | 3.63 (2.07) | 7.09 (11.27) |
Th17 | 0.84 (0.51) | 0.83 (0.43) | 0.78 (0.52) | 1.50 (1.05) |
Tr1 | 7.03 (5.56) | 7.93 (3.34) | 7.95 (4.43) | 2.01 (1.28) |
Treg | 5.58 (2.72) | 8.59 (6.51) | 5.87 (3.45) | 21.11 (10.83) |
Condition | Baseline | Follow-up | ||
Viability | 90.85 (4.88) | 92.00 (5.03) | ||
Recovery* | 75.95 (15.36) | 39.79 (32.42) |
Comparison of sample condition recovery by time point was significant (Diff = 36.16 (19.23); p < 0.0001).